摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-(6-((3-fluoro-5-hydroxy-4-morpholinophenyl)amino)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide

中文名称
——
中文别名
——
英文名称
N-(3-(6-((3-fluoro-5-hydroxy-4-morpholinophenyl)amino)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide
英文别名
N-[3-[6-(3-fluoro-5-hydroxy-4-morpholin-4-ylanilino)-1-(oxan-2-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]prop-2-enamide
N-(3-(6-((3-fluoro-5-hydroxy-4-morpholinophenyl)amino)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide化学式
CAS
——
化学式
C29H30FN7O4
mdl
——
分子量
559.6
InChiKey
ABWBGNXZYSHXAO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    41
  • 可旋转键数:
    7
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    127
  • 氢给体数:
    3
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    N-(3-(6-chloro-1-(terahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide5-Amino-3-fluoro-2-morpholinophenol 作用下, 以to yield N-(3-(6-((3-fluoro-5-hydroxy-4-morpholinophenyl)amino)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide, which的产率得到N-(3-(6-((3-fluoro-5-hydroxy-4-morpholinophenyl)amino)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)phenyl)acrylamide
    参考文献:
    名称:
    Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
    摘要:
    在一个方面,本发明涉及替代的N-(3-(嘧啶-4-基)苯基)丙烯酰胺类似物、其衍生物和相关化合物,它们可用作BTK激酶的抑制剂;制备这些化合物的合成方法;包括这些化合物的药物组合物;以及使用这些化合物和组合物治疗与BTK激酶功能障碍相关的疾病的方法。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。
    公开号:
    US09296703B2
点击查看最新优质反应信息

文献信息

  • Substituted N-(3-(Pyrimidin-4-YL)Phenyl)Acrylamide Analogs as Tyrosine Receptor Kinase BTK Inhibitors
    申请人:UNIVERSITY OF UTAH RESEARCH FOUNDATION
    公开号:US20150368208A1
    公开(公告)日:2015-12-24
    In one aspect, the invention relates to substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs, derivatives thereof, and related compounds, which are useful as inhibitors of the BTK kinase; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the BTK kinase. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    在某个方面,本发明涉及取代的N-(3-(嘧啶-4-基)苯基)丙烯酰胺类似物、其衍生物和相关化合物,它们作为BTK激酶抑制剂是有用的;制备这些化合物的合成方法;包括这些化合物的制药组合物;以及使用这些化合物和组合物治疗与BTK激酶功能障碍相关的疾病的方法。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。
  • SUBSTITUTED N-(3-(PYRIMIDIN-4-YL)PHENYL)ACRYLAMIDE ANALOGS AS TYROSINE RECEPTOR KINASE BTK INHIBITORS
    申请人:University of Utah Research Foundation
    公开号:EP2903971B1
    公开(公告)日:2019-06-12
  • US9296703B2
    申请人:——
    公开号:US9296703B2
    公开(公告)日:2016-03-29
  • [EN] SUBSTITUTED N-(3-(PYRIMIDIN-4-YL)PHENYL)ACRYLAMIDE ANALOGS AS TYROSINE RECEPTOR KINASE BTK INHIBITORS<br/>[FR] ANALOGUES DE N-(3-(PYRIMIDIN-4-YL)PHÉNYL) SUBSTITUÉ UTILISÉS EN TANT QU'INHIBITEURS DE RÉCEPTEUR TYROSINE KINASE BTK
    申请人:UNIV UTAH RES FOUND
    公开号:WO2014055934A2
    公开(公告)日:2014-04-10
    In one aspect, the invention relates to substituted N-(3-(pyrimidin-4- yl)phenyl)acrylamide analogs, derivatives thereof, and related compounds, which are useful as inhibitors of the BTK kinase; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the BTK kinase. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
    申请人:University of Utah Research Foundation
    公开号:US09296703B2
    公开(公告)日:2016-03-29
    In one aspect, the invention relates to substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs, derivatives thereof, and related compounds, which are useful as inhibitors of the BTK kinase; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the BTK kinase. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    在一个方面,本发明涉及替代的N-(3-(嘧啶-4-基)苯基)丙烯酰胺类似物、其衍生物和相关化合物,它们可用作BTK激酶的抑制剂;制备这些化合物的合成方法;包括这些化合物的药物组合物;以及使用这些化合物和组合物治疗与BTK激酶功能障碍相关的疾病的方法。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。
查看更多